Abstract:
A medical prosthesis includes a body having a silicone skin and a silicone foam body core. The skin and foam body core are both resilient. The core includes a plurality of voids and a plurality of discontinuities. Some of the discontinuities communicate with more than one void.
Abstract:
A foam material is provided that is formed from a body of silicone having a cellular structure formed by a plurality of interconnected voids. The voids have a relatively high volume of between about 0.06545 to about 268.0832 mm3 and more typically about 65.45 to about 179.5948 mm3. The foam material displays unique tactile properties.
Abstract:
To provide a porous polyimide resin film having a high aperture ratio. A method for producing a porous polyimide film comprising removing fine particles from a polyimide resin-fine particle composite film to thereby obtain a porous polyimide resin film, in which the method comprises either removing at least a part of a polyimide resin portion of the polyimide resin-fine particle composite film prior to removing the fine particles, or removing at least a part of the porous polyimide resin film subsequent to removing the fine particles.
Abstract:
The present invention relates to a process for the processing of perfluoropolymer materials, and to the use of the resultant products in different potential applications, such as in the medical device field.
Abstract:
A method for forming an open cell texturized surface in a silicone elastomer layer of a breast implant, or other medical implant, is created by forming a layer of uncured silicone elastomer, applying a coating of particles to the surface thereof, and curing the layer by heating it at an elevated temperature which also volatilizes the particles such that their constituent gases boil through the surface of the layer and create the texturing.
Abstract:
A method for forming an open cell texturized surface in a silicone elastomer layer of a breast implant, or other medical implant, is created by forming a layer of uncured silicone elastomer, applying a coating of particles to the surface thereof, and curing the layer by heating it at an elevated temperature which also volatilizes the particles such that their constituent gases boil through the surface of the layer and create the texturing.
Abstract:
A method for making composite PMC polymeric materials, based on TFE polymers and/or copolymers, having a controlled porosity and modularly adjustable properties, said method comprising the steps of: a) mixing a TFE polymer or copolymer with one or more organic, inorganic substances in a solid or liquid form, to adjust the chemical, physical and mechanical properties of the composite material; b) adding to the mixture chemical organic and inorganic composites and complex mixtures thereof, said substances being adapted to sublimate or quickly evaporate or transform into a gas by a thermal processing in a temperature range from 30° to 380°C, B Composites, said "B Composites" being absent in the end product after sintering; c) processing said mixture to form articles; d) thermally processing, under vacuum, said articles to form a controlled porosity; and e) thermally sintering said controlled porosity articles of said step d).
Abstract:
The present application provides a biocompatible medical implant comprising poly(4-hydroxybutyrate) homopolymer. Optionally, the implant is sterile. The implant may, for example, be selected from guided tissue regeneration devices, tissue engineering devices, tissue engineering scaffolds, foams, coatings, meshes, microparticles, resorbable wound closure materials such as suturing and stapling materials, controlled release devices, drug delivery devices, cell encapsulation devices, targeted delivery devices, devices with biocompatible coatings, orthopedic devices, prosthetics, bone cements (including adhesives and/or structural fillers), diagnostic devices, rods, bone screws, pins, surgical sutures, stents, patches (such as hernial patches and pericardial patches), devices with vascular applications, and tubes suitable for the passage of bodily fluids. The invention also provides a method for preparing a biocompatible polyhydroxyalkanoate that has a controlled degradation rate of less than one year under physiological conditions, and optionally processing thus prepared polyhydroxyalkanoate into a medical device. The biocompatible polyhydroxyalkanoate used in the method may, for example, be produced by a process selected from the group consisting of fermentation, enzymatic synthesis, chemical synthesis, melt processing, reactive blending, and recombinant techniques. The biocompatible polyhydroxyalkanoate used in the method may, for example, be derived by fermentation (a) using a co-feed, and/or (b) by a fermentation process that uses transgenic bacteria.